Physician profile
Michael Drew Anthony
NPI 1679641450
$7,228.42
in general payments reported to CMS, 2019-2025
35 companies · $837 in 2025
The $837 reported for 2025 was more than what 90% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $978 · 2021: $1,475 · 2022: $1,039 · 2023: $1,022 · 2024: $824 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,683.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,356.68 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $731.11 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $718.44 | 2019-2025 | Ofev, Jardiance, Synjardy |
| Lilly USA, LLC | $415.07 | 2020-2025 | Jardiance, Mounjaro, Emgality |
| Amgen INC. | $372.96 | 2019-2025 | Evenity, Prolia |
| Novo Nordisk INC | $349.82 | 2019-2024 | Rybelsus, Ozempic |
| Mylan Specialty L.P. | $298.11 | 2021-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $272.33 | 2019-2022 | |
| Pfizer INC. | $252.60 | 2019-2025 | |
| Abbvie INC. | $227.53 | 2021-2025 | Vraylar |
| Merck Sharp & Dohme LLC | $189.46 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $165.31 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $117.02 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $116.95 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.10 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $63.33 | 2021-2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $48.67 | 2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $47.17 | 2021-2022 | |
| Organon LLC | $46.63 | 2025 | Vtama |
| Sunovion Pharmaceuticals INC. | $35.85 | 2019 | |
| Dexcom, INC. | $34.27 | 2021-2025 | Dexcom G6 Transmitter |
| Inari Medical, INC. | $34.12 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $34.09 | 2019 | |
| Daiichi Sankyo INC. | $28.41 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $24.61 | 2024 | Zoryve |
| Mayne Pharma Commercial LLC | $22.53 | 2021 | |
| Phathom Pharmaceuticals, INC. | $21.02 | 2024 | Voquezna |
| Insulet Corporation | $20.86 | 2021 | |
| Glaxosmithkline, LLC. | $15.99 | 2021 | |
| Sanofi Pasteur INC. | $15.91 | 2019 | |
| Seqirus USA INC | $15.17 | 2025 | Flucelvax, Fluad |
| Allergan, INC. | $15.11 | 2020 | |
| Amarin Pharma, INC. | $14.70 | 2019 | |
| Pacira Therapeutics, INC. | $13.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.